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Abstract
Background: Despite increasing knowledge of the prevalence of borderline personality disorder (BPD) in the
general population, and rising awareness of mental disorders both as a categorical and a dimensional construct,
research is still lacking on the prevalence of the number of BPD symptoms and their associated consequences,
such as comorbidity, disability, and the use of mental health services) in the general population.
Methods: Data were obtained from the second wave of the Netherlands Mental Health Survey and Incidence
Study-2 (N = 5303), a nationally representative face-to-face survey of the general population. BPD symptoms were
measured by means of questions from the International Personality Disorder Examination. Comorbidity of common
mental disorders was assessed with the Composite International Diagnostic Interview version 3.0.
Results: Of the total population studied, 69.9 % reported no BPD symptoms, while 25.2 % had 1–2 symptoms,
3.8 % had 3–4 symptoms, and 1.1 % had ≥ 5 BPD symptoms. The number of BPD symptoms reported was found
to be positively associated with not living with a partner, having no paid job, and/or having a comorbid mood,
anxiety or substance use disorder. Even after adjustment for sociodemographic characteristics and comorbidity,
the number of BPD symptoms turned out to be uniquely associated with disability. It also showed a positive
relationship with using services for dealing with mental health problems, although this relationship was strongly
affected by the presence of comorbid disorders.
Conclusions: Because even a relatively low number of BPD symptoms appears to be associated with psychiatric
comorbidity and functional disability, not only full-blown BPD but also subthreshold levels of BPD symptoms need
to be identified in clinical practice and research.
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Background
The epidemiology of borderline personality disorder
(BPD) has been studied in various large adult population-
based surveys, mainly in the United States. These studies
have shown that the prevalence rates for BPD vary be-
tween 0.5 % [1] and 1.4 % [2–6] of the total population.
Two studies, based on data from the National Epidemio-
logic Survey on Alcohol and Related Conditions, have
found higher rates, of 2.7 % [7] and 5.9 % [8] respectively,
depending on how strictly the diagnostic rules are applied.
A prudent assumption seems to be that, generally speak-
ing, the population prevalence rate of BPD is circa 1 % [9].
Regardless of differences in prevalence rates, there is
consistent evidence for a high comorbidity of BPD with
common mental disorders, such as mood, anxiety and
substance use disorders (e.g. [3, 5, 7, 8]). Yet it remains
unclear whether, after adjustment for comorbidity with
common mental disorders, BPD in the general popula-
tion is also linked to mental disability and the use of ser-
vices for mental health problems. There is only little
research available on this topic, and existing studies
show mixed findings [5, 7, 8, 10, 11].
In recent years, the awareness has risen that mental
disorders can be viewed as both as a categorical con-
struct (i.e. the presence or absence of a certain disorder)
and a dimensional construct (i.e. a severity dimension,
ranging from normality with hardly any symptoms to a
full-blown disorder, when someone displays a minimum
number of symptoms and suffers from associated dis-
ability). Although personality pathology is probably best
described by a single severity dimension [12, 13], we are
not aware of any research having been conducted on the
prevalence rates of various numbers of BPD symptoms
(an indication of severity) in the general population, and
the associated consequences of such symptoms.
This paper attempts to fill this research gap by analys-
ing data from the second wave (N = 5303) of the
Netherlands Mental Health Survey and Incidence Study-
2 (NEMESIS-2), which is a nationally representative sur-
vey of the general adult population. Our main research
questions are: (1) What is the prevalence of various
numbers of BPD symptoms in the general population,
and what are their associated sociodemographic corre-
lates? (2) To what extent does the number of BPD symp-
toms people display co-occur with common mental
disorders? (3) After adjustment for sociodemographic
characteristics and comorbidity, to what extent is mental
disability associated with the number of BPD symptoms?
(4) Is health care mainly sought for BPD symptoms or
for the associated disorders? To answer these questions,
we defined four categories of number of BPD symptoms,
namely, having 0, 1–2, 3–4 and ≥ 5 symptoms. This
categorization reflects a certain severity dimension, ranging
from having no BPD symptoms to potentially suffering
from BPD. People with ≥ 5 BPD symptoms could be viewed
as suffering from BPD, because they fulfil the required
number of criteria for a BPD diagnosis. BPD symptoms
were assessed by means of questions from the International
Personality Disorder Examination.
Methods
NEMESIS-2 is a psychiatric epidemiological cohort
study of the Dutch general population aged 18 to
64 years. It is based on a multistage, stratified random
sampling of households, with one respondent randomly
selected in each household. Based on the most recent
birthday at first contact within the household, an indi-
vidual aged 18–64 years with sufficient fluency in the
Dutch language was randomly selected. Addresses of
institutions and thus institutionalized individuals (i.e.
those living in hospices, prisons) were excluded. Those
temporarily living in institutions, however, could be inter-
viewed later during the fieldwork if they returned home.
In the first wave (T0), performed from November
2007 to July 2009, a total of 6646 persons were inter-
viewed (response rate 65.1 %; average interview
duration: 95 min). This sample was nationally repre-
sentative, although younger subjects were somewhat
underrepresented [14]. The interviews were laptop
computer-assisted and almost all were held at the re-
spondent’s home.
All T0 respondents were approached for follow-up,
three years after T0 from November 2010 to June 2012.
Of this group, 5303 persons could be interviewed again
(response rate 80.4 %, with those deceased excluded;
average interview duration: 84 min). Attrition rate was
not significantly associated with all main categories and
individual 12-month mental disorders at baseline, after
controlling for sociodemographic characteristics [15].
The mean period between both interviews was 3 years
and 7 days.
For this paper, data from the second wave were
used (N = 5303), because data on BPD symptoms were
then collected.
The study was approved by a medical ethics commit-
tee (the Medical Ethics Review Committee for Institu-
tions on Mental Health Care, METIGG). After having
been informed about the study aims, respondents
provided written informed consent. A more compre-
hensive description of the design is provided in De
Graaf et al. [14].
The face-to-face interviews were conducted by trained
professional interviewers of the fieldwork agency GfK
(Growth from Knowledge) Panel Services Benelux, with
their team of five supervisors. Interviewers were selected
on their experience with systematic face-to-face data
collection, experience with sensitive topics and ability to
achieve a good response in other studies. Fieldwork was
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monitored over the entire data collection period by the
NEMESIS-investigators and the fieldwork agency (for
more information on quality checks of the data, see
[14]). At the second wave, the best interviewers of the
first wave were selected to do this job. To increase the
response rate, respondents were as much as possible re-
interviewed by the same interviewer as at the first wave.
Borderline personality disorder (BPD) symptoms
BPD symptoms were measured by means of eight ques-
tions from the International Personality Disorder Exam-
ination (IPDE) [16, 17]; the questions form part of the
Composite International Diagnostic Interview (CIDI) 3.0
[5, 18]. This measure uses a true-false response format,
with scores being assigned on the basis of the total sum
of ‘true’ responses. A higher score on this measure is
indicative of a greater number of BPD symptoms. In a
clinical reappraisal interview, performed in a subsample
of the National Comorbidity Survey Replication (NCS-
R) in the United States, it was found that such interview
questions allow for a valid assessment of BPD [5].
For the present study, we defined four categories of
number of BPD symptoms, namely, having 0, 1–2, 3–4,
and ≥ 5 symptoms. People with ≥ 5 BPD symptoms could
be viewed as suffering from BPD, because they fulfil the
required number of DSM-IV criteria (at least 5 of the 9)
for a BPD diagnosis.
Comorbidity of common mental disorders
DSM-IV diagnoses of common mental disorders were
made using the CIDI 3.0 - a fully structured lay-
administered diagnostic interview. This instrument was
developed and adapted for use in the World Mental
Health Survey Initiative [19]. The CIDI 3.0 version used
in NEMESIS-2 was an improvement on the Dutch one
used in this initiative.
The comorbid disorders considered in this paper in-
clude: mood disorders (i.e. major depression, dysthymia,
and bipolar disorder), anxiety disorders (i.e. panic dis-
order, agoraphobia without panic disorder, social phobia,
specific phobia, and generalized anxiety disorder) and
substance use disorders (i.e. alcohol/drug abuse and de-
pendence). Comorbidity of any disorder refers to any of
the above-mentioned mental disorders.
Clinical calibration studies in various countries [20]
found that the CIDI 3.0 assesses mood, anxiety and sub-
stance use disorders with generally good validity in com-
parison to blinded clinical reappraisal interviews.
For this paper, the occurrence of comorbid disorders
between baseline and follow-up were used.
Vulnerability to mental disorders
To gain some further insight into the association between
number of BPD symptoms and comorbid disorders, we
also investigated the association between BPD symptoms
and vulnerability to mental disorders. As vulnerability in-
dicators we used: childhood abuse (whether before age
16 years one had experienced emotional neglect, psycho-
logical abuse, or physical abuse on two or more occasions,
or sexual abuse on one or more occasion; these questions
based on self-report were used before in the studies
NEMESIS-1 and NESDA (the Netherlands Study of
Depression and Anxiety) (see e.g. [21–24]); to increase the
likelihood of these experiences being reported, they were
not mentioned as such, but were listed in a booklet and
referred to by number) and lifetime mental health prob-
lems of parents (at least one biological parent ever
having been treated by a psychiatrist, or hospitalized
in a mental institution, or ever having exhibited one
or more of the following problems: severe depression,
delusions or hallucinations, severe anxiety or phobias,
alcohol abuse, drug abuse, regular problems with the
police, and suicidal behaviour).
Mental disability
Current mental disability was assessed with three sub-
scales of the Medical Outcomes Study Short Form
Health Survey (MOS SF-36) [25]: social functioning, role
emotional functioning and mental health in the past
4 weeks.
Social functioning involves problems in one’s normal
social activities as a result of somatic or emotional prob-
lems; a 2-item, 6-point subscale of the MOS SF-36
(Cronbach’s alpha = 0.78). Role emotional functioning in-
volves problems at work or in other daily activities as a
result of emotional problems; a 3-item, 2-point subscale
of the MOS SF-36 (Cronbach’s alpha = 0.88). Mental
health was assessed with a frequently used screener for
mood and anxiety disorders [26]; a 5-item, 6-point sub-
scale of the MOS SF-36 (Cronbach’s alpha = 0.79).
Service use for mental health problems
Service use refers to at least one contact made in the
general medical care or mental health care sector for
emotional or addiction problems between baseline and
follow-up. General medical care includes general practi-
tioners, company doctors, social work, home care or
district nurses, physiotherapists or haptonomists, med-
ical specialists or other professionals working within this
care sector. Mental health care includes psychiatrists,
psychologists, psychotherapists, part-time or full-time
psychiatric treatment.
Sociodemographic characteristics
The sociodemographic characteristics and potential con-
founders used were: age (in four age categories because
age is not always linearly related to the outcome meas-
ure, in this case BPD symptoms), gender, education level,
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living situation (i.e. living with a partner or not), and job
status (i.e. having a paid job or not).
Analyses
All analyses were performed with STATA version 12.1,
using weighted data to correct for differences in the
response rates in several sociodemographic groups at
both waves and differences in the probability of selection
of respondents within households at baseline. Robust
standard errors were calculated in order to obtain cor-
rect 95 % confidence intervals and p-values [27].
First, sociodemographic characteristics of the four
categories of number of BPD symptoms were calculated
using simple descriptive analyses (Table 1). In addition
to the overall p-values between two categorical variables
(e.g. between gender and number of BPD symptoms),
we calculated p-values between a certain sociodemo-
graphic variable and all possible combinations of BPD
symptom categories (i.e. for gender, we calculated dif-
ferences between the category with 0 symptoms com-
pared to the category with respectively 1–2 symptoms,
3–4 symptoms, and ≥ 5 symptoms, et cetera; in total 6
possible comparisons between the four BPD symptom
severity categories).
Second, multivariate logistic regression analyses were
performed to examine to what extent number of BPD
symptoms is associated with a variety of common mental
disorders, adjusted for gender and age (Table 2). By
changing the reference category in the logistic regression
analyses we were able to calculate the differences between
all possible combinations of number of BPD symptom cat-
egories on comorbid disorders. Results of multivariate
logistic regression analyses are usually expressed in
adjusted odds ratios, but could also be expressed in
adjusted average predicted probabilities by using the
margins command (http://www.ats.ucla.edu/stat/stata/
dae/logit.htm). We opted for this last mode, because it
enabled us to show the probabilities of mental disor-
ders in all BPD symptom severity categories (including
the reference category). To gain further insight into
the consistency of the association between number of
BPD symptoms and comorbid disorders, we also in-
vestigated the association between BPD symptoms and
vulnerability to mental disorders in the same way as
described above.
Third, multivariate linear and logistic regression ana-
lyses were used to examine to what extent number of
BPD symptoms is associated with mental disability and
service use for mental health problems (Table 3), ad-
justed for sociodemographic characteristics (model 1)
and additionally for any comorbid mood, anxiety or sub-
stance use disorder (model 2). Again, by changing the
reference group in the regression analyses we were able
to calculate the differences between all possible
combinations of number of BPD symptom categories
with regard to mental disability and health service use.
The results were expressed in adjusted averages and ad-
justed average predicted probabilities, respectively, by
using the margins command, to be able to show the av-
erages on mental disability and the probabilities of
health service use in all BPD symptom severity categor-
ies (including the reference category).
Two-tailed testing procedures were used with 0.05
alpha levels in the main analyses except the tests to cal-
culate the differences between all possible combinations
of number of BPD symptom categories on a certain vari-
able, where alpha levels of 0.01 and 0.001 were used, be-
cause of the large number of analyses.
Results
Of the population studied, 69.9 % reported having no
BPD symptoms, while 25.2 % had 1–2 symptoms, 3.8 %
had 3–4 symptoms, and 1.1 % had ≥ 5 BPD symptoms.
The number of BPD symptoms turned out to be signifi-
cantly related to gender, age, education level, living situ-
ation, and job status (Table 1).
With respect to gender, the category of people with ≥ 5
symptoms included a significantly higher proportion of
females as compared to the categories of people with 0
and 1–2 symptoms. Age differences were less pro-
nounced, although the category with 0 symptoms con-
sisted of slightly older respondents. The latter category
was further characterized by a significantly larger pro-
portion of higher professionals or university educated
adults, as compared to the categories that had 1–2 and
3–4 symptoms. The differences between all possible
combinations of number of BPD symptom categories
were most pronounced with respect to the proportion of
respondents living without a partner and those without
a paid job. Generally speaking, the more BPD symptoms
a respondent had, the more likely it was he or she was
not living with a partner and had no paid job.
After adjustment for gender and age, respondents with
a higher number of BPD symptoms turned out to be sig-
nificantly more likely to suffer from various common
mental disorders (Table 2). It was also found that, for
the three main groups of mental disorders, as well as for
any comorbid disorder, the differences between all pos-
sible combinations of number of BPD symptom categor-
ies reflected the anticipated trend and were highly
significant, except for the difference between the two
categories with the larger number of BPD symptoms. Al-
though the category with ≥5 symptoms had higher aver-
age predicted probabilities of the main groups of mental
disorders and any mental disorder compared to the
category with 3–4 symptoms, these differences were not
significant at p < .01, probably because of the small num-
ber of respondents in these categories (58 and 186,
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respectively). A similar picture was found for suicidal be-
haviour and childhood abuse: respondents with a higher
number of BPD symptoms were more likely to report such
experiences; the differences between the category with 3–
4 and the category with ≥ 5 symptoms were not significant
at p < .01. However, these last two categories did differ
with respect to the proportion of parents with mental
health problems. Whereas a minority of those with 3–4
symptoms had a parent with a psychiatric history, the re-
verse was true for respondents with ≥ 5 symptoms.
A comparison of the mental disability scores of those
with different numbers of BPD symptoms showed that a
higher number of BPD symptoms was positively associ-
ated with a higher likelihood of mental disability, even
after adjustment for sociodemographic characteristics
and any comorbid mood, anxiety or substance use dis-
order (Table 3). This means that the severity of BPD
symptoms is uniquely related to higher mental disability
scores. Again, we found that the differences between all
possible combinations of number of BPD symptom cat-
egories were incremental and highly significant, except
for the two categories with the largest number of symp-
toms. As this implies, a larger number of BPD symptoms
is associated with higher mental disability scores. Al-
though the category with ≥ 5 symptoms had lower aver-
ages for social and role emotional functioning and
mental health compared to the category with 3–4 symp-
toms, these differences were not significant at p < .01;
again, this is probably due to the small number of re-
spondents in these categories.
A different picture emerges when it comes to the use
of health services by respondents with a relatively high
number of BPD symptoms. After adjustment for socio-
demographic characteristics, respondents with a larger
number of BPD symptoms turned out to be significantly
more likely to use services for their mental health prob-
lems. However, these probabilities were substantially
lower after adjustment for additional comorbid mood,
anxiety or substance use disorders; the number of BPD
symptoms was still uniquely related to the use of health
services, but respondents appeared to seek care mainly
for comorbid mental disorders. As to the differences
between all possible combinations of number of BPD
symptom categories, significant differences were only
found between respondents with 0 symptoms on the
one hand and respondents with 1–2, 3–4 and ≥ 5 symp-
toms on the other. This means that, although the num-
ber of BPD symptoms is indeed significantly related to a
more frequent use of health care services, the main dis-
tinguishing factor is whether or not someone has any
BPD symptoms at all.
Discussion
Key findings
To the best of our knowledge, this is the first study
which relates the number of BPD symptoms in the
Table 1 Sociodemographic characteristics of categories with number of borderline personality disorder (BPD) symptoms in the general
population (N = 5303), in weighted column percentages
Total 0 BPD symptoms 1–2 BPD symptoms 3–4 BPD symptoms ≥5 BPD symptoms P value
n (%) 5303 (100) 3783 (69.9) 1276 (25.2) 186 (3.8) 58 (1.1)
Sociodemographic characteristics
Female gender 49.5 50.1 46.0 56.0 72.6 .000c,e
Age at interview .023
21–37 32.0 30.2 36.3 37.9 31.1
38–47 24.5 24.1 24.8 27.3 30.9
48–57 23.3 24.0 21.5 21.7 26.3
58–67 20.2 21.7 17.4 13.0 11.7
Education .000a,b
Lower secondary 29.5 26.9 35.1 36.9 43.4
Higher secondary 41.6 42.3 39.4 44.4 40.6
Higher professional/university 28.8 30.8 25.5 18.7 15.9
Living without partner 29.9 26.7 34.2 51.0 62.1 .000a,b,c,d,e
No paid job 24.8 23.2 25.6 43.1 47.4 .000b,c,d,e
a: category 0 symptoms versus category 1–2 symptoms was significantly different (P < .01; in bold at P < .001)
b: category 0 symptoms versus category 3–4 symptoms was significantly different (P < .01; in bold at P < .001)
c: category 0 symptoms versus category ≥ 5 symptoms was significantly different (P < .01; in bold at P < .001)
d: category 1–2 symptoms versus category 3–4 symptoms was significantly different (P < .01; in bold at P < .001)
e: category 1–2 symptoms versus category ≥ 5 symptoms was significantly different (P < .01; in bold at P < .001)
f: category 3–4 symptoms versus category ≥ 5 symptoms was significantly different (P < .01; in bold at P < .001)
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general population to comorbidity of common mental
disorders and mental disability. Previous population
studies have confined themselves mostly to assessing the
prevalence rate of BPD diagnosis and its associated cor-
relates and consequences. The present study builds on
existing knowledge by showing that, in a representative
population sample of adults, even low numbers of BPD
symptoms are associated with psychiatric comorbidity
and functional disability. Furthermore, it demonstrates
that the number of BPD symptoms is associated with
more frequent use of services for mental health prob-
lems, but that such care is mainly sought for comorbid
mental disorders.
Strengths and limitations
For this paper, data were used from NEMESIS-2. Al-
though for most parameters NEMESIS-2 is representa-
tive of the Dutch population, people with an insufficient
mastery of Dutch, those with no permanent residential
address and the institutionalized are underrepresented
in this sample. Hence, our findings cannot be general-
ized to these groups.
BPD symptoms were measured with eight questions
from the International Personality Disorder Examination
(IPDE). Despite indications of the validity of these IPDE
questions for assessing BPD diagnoses [5], its properties
make it unsuitable for use in clinical practice. However,
the questionnaire can be used in epidemiological studies
where the focus is on determining prevalence rates and
associated correlates among groups of individuals. The
present study yields clear indications of its validity,
showing that respondents with a higher number of BPD
symptoms are consistently more likely to report suicidal
behaviour, all main groups of mental disorders, a vulner-
ability to these disorders, and a higher prevalence of
mental disability. In order to establish the extent to
which the present findings can be replicated, future
population studies need to go beyond the exclusive use
of screening questions and employ clinical interviews to
assess full borderline personality disorder, as well as
Table 2 Clinical characteristics of categories with number of borderline personality disorder (BPD) symptoms in the general population
(N = 5303), in weighted average predicted probabilities adjusted for gender and age (%)
Total 0 BPD symptoms 1–2 BPD symptoms 3–4 BPD symptoms ≥5 BPD symptoms P for trend
% % [95 % CI] % [95 % CI] % [95 % CI] % [95 % CI]
3-year mental disorders
Any mood disorder 8.4 3.76 [2.87,4.66] 14.46 [11.87,17.04] 36.18 [27.74,44.62] 58.00 [40.27,75.74] .000a,b,c,d,e
Major depression 7.5 3.45 [2.63,4.28] 13.52 [11.03,16.01] 30.67 [23.21,38.12] 40.53 [24.86,56.20] .000a,b,c,d,e
Dysthymia 0.7 0.03 [–0.03,0.09] 1.41 [0.32,2.49] 3.93 [–0.90,8.77] 5.41 [–1.55,12.38] .000a,b,c
Bipolar disorder 0.8 0.31 [0.03,0.58] 0.80 [0.18,1.41] 4.53 [1.61,7.45] 15.74 [4.60,26.88] .000b,c,d,e
Any anxiety disorder 7.9 4.87 [3.88,5.87] 11.95 [8.60,15.31] 25.01 [18.37,31.65] 40.25 [27.24,53.27] .000a,b,c,d,e
Panic disorder 1.9 0.88 [0.41,1.36] 3.81 [1.89,5.73] 4.38 [2.42,6.34] 11.58 [2.12,21.04] .000a,b,c
Agoraphobia 0.4 0.29 [–0.01,0.60] 0.33 [0.09,0.57] 2.86 [–0.04,5.76] 3.35 [–0.55,7.25] .004b,c,d,e
Social phobia 2.5 1.15 [0.57,1.74] 3.82 [2.16,5.48] 11.95 [6.62,17.28] 19.94 [4.97,34.91] .000a,b,c,d,e
Specific phobia 3.5 2.68 [1.87,3.49] 4.71 [2.87,6.55] 7.41 [3.86,10.96] 13.15 [4.49,21.80] .000b,c
GAD 1.6 0.77 [0.43,1.10] 2.77 [1.36,4.19] 6.89 [3.19,10.60] 5.32 [–0.80,11.44] .000a,b,c,d
Any substance use disorder 5.7 3.82 [2.88,4.76] 7.40 [5.49,9.31] 18.58 [11.80,25.36] 31.32 [17.46,45.17] .000a,b,c,d,e
Alcohol abuse 3.6 3.05 [2.18,3.92] 4.73 [3.04,6.41] 4.32 [1.49,7.15] 3.47 [–3.20,10.14] .030
Alcohol dependence 0.9 0.24 [0.08,0.39] 1.12 [0.56,1.69] 7.27 [2.79,11.75] 19.23 [2.23,36.23] .000a,b,c,d,e
Drug abuse 0.9 0.60 [0.14,1.07] 1.03 [0.18,1.88] 2.57 [–0.10,5.23] 8.16 [–0.33,16.65] .003c,e
Drug dependence 0.6 0.08 [–0.00,0.16] 0.74 [0.23,1.25] 5.72 [0.30,11.14] 8.44 [–0.32,17.19] .000a,b,c,d,e
Any mental disorder 17.4 10.96 [9.59, 12.33] 25.97 [22.10, 29.84] 57.18 [48.11,66.26] 74.76 [62.99,86.53] .000a,b,c,d,e
3-year suicidal behaviour 2.4 0.94 [0.48,1.40] 3.61 [2.13,5.08] 14.63 [8.03,21.23] 29.87 [16.37,43.38] .000a,b,c,d,e
Vulnerability to mental disorders
Childhood abuse 27.3 22.83 [21.28,24.38] 35.31 [31.76,38.85] 48.63 [40.20,57.06] 58.12 [42.01,74.23] .000a,b,c,d,e
Lifetime mental health problems of parents 31.4 28.58 [26.32,30.83] 36.07 [32.36,39.78] 42.05 [34.32,49.77] 65.90 [54.73,77.06] .000a,b,c,e,f
a: category 0 symptoms versus category 1–2 symptoms was significantly different (P < .01; in bold at P < .001)
b: category 0 symptoms versus category 3–4 symptoms was significantly different (P < .01; in bold at P < .001)
c: category 0 symptoms versus category ≥ 5 symptoms was significantly different (P < .01; in bold at P < .001)
d: category 1–2 symptoms versus category 3–4 symptoms was significantly different (P < .01; in bold at P < .001)
e: category 1–2 symptoms versus category ≥ 5 symptoms was significantly different (P < .01; in bold at P < .001)
f: category 3–4 symptoms versus category ≥ 5 symptoms was significantly different (P < .01; in bold at P < .001)
ten Have et al. BMC Psychiatry  (2016) 16:249 Page 6 of 10
Table 3 Current mental disability and service use for mental health problems of categories with number of borderline personality disorder (BPD) symptoms in the general population
(N = 5303), in weighted adjusted averages (Mean) or adjusted average predicted probabilities (%)
Total 0 BPD symptoms 1–2 BPD symptoms 3–4 BPD symptoms ≥5 BPD symptoms P for trend
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
Mean Mean [95 % CI] Mean [95 % CI] Mean [95 % CI] Mean [95 % CI] Mean [95 % CI] Mean [95 % CI] Mean [95 % CI] Mean [95 % CI]
Mental disability





















































% % [95 % CI] % [95 % CI] % [95 % CI] % [95 % CI] % [95 % CI] % [95 % CI] % [95 % CI] % [95 % CI]
3-year service use for
mental health problems






























a: category 0 symptoms versus category 1–2 symptoms was significantly different (P < .01; in bold at P < .001)
b: category 0 symptoms versus category 3–4 symptoms was significantly different (P < .01; in bold at P < .001)
c: category 0 symptoms versus category ≥ 5 symptoms was significantly different (P < .01; in bold at P < .001)
d: category 1–2 symptoms versus category 3–4 symptoms was significantly different (P < .01; in bold at P < .001)
e: category 1–2 symptoms versus category ≥ 5 symptoms was significantly different (P < .01; in bold at P < .001)
f: category 3–4 symptoms versus category ≥ 5 symptoms was significantly different (P < .01; in bold at P < .001)
Model 1: adjusted for sociodemographic characteristics (gender, age, education level, living situation, paid job status)
Model 2: adjusted for sociodemographic characteristics (model 1) as well as for mental disorders (any mood, any anxiety, any substance use disorder)













clinical reappraisal interviews to validate existing
screeners for borderline personality disorder.
Just as in the NCS-R [28], in our study one criterion
for BPD (namely, recurrent suicidal behaviour, gestures
or threats, or self-mutilating behaviour) was not assessed
in the IPDE screening questionnaire. However, in the sui-
cidality module of the CIDI 3.0, respondents were asked
about whether or not they had ever had experienced sui-
cidal ideation, or made suicide plans and/or attempts. As
expected, the more BPD symptoms respondents had, the
more often they reported having experienced suicidal be-
haviour in the preceding years; this confirms the validity
of the IPDE questionnaire.
Underreporting and recall problems might conceivably
have compromised the assessment of respondents of any
BPD symptoms they might have and might have had,
especially in those cases where such symptoms occurred
a long time ago [29]. The IPDE questions refer to rather
stable personality characteristics (i.e. ‘What you are like
most of the time?’ ‘What has been typical of you
throughout your life?’). Mental disorders were assessed
over a 3-year period, which could increase the likelihood
of recall bias. Besides, it is conceivable that people with
BPD symptoms perceive their mental health in a more
negative way. We tried to minimize this type of bias by
using a sound diagnostic instrument for the assessment
of mental disorders. All in all, it is difficult to estimate
the exact extent to which underreporting, recall or re-
port problems may have influenced our findings.
In NEMESIS-2, the most common mental disorders
were assessed. However, not all cluster B personality disor-
ders were recorded in the dataset: the same goes for clus-
ter A and cluster C personality disorders. This means that
impairment associated with these disorders and the use of
health care services could not be studied. Previous re-
search has shown, however, that it is comorbid common
mental disorders and not comorbid personality disorders
that ultimately determine the social functioning of people
with BPD in the general population; the same goes for
seeking treatment [10]. As this suggests, the associations
found were hardly affected by our inability to adjust for
other personality disorders.
Our study relates the number of BPD symptoms to co-
morbidity of common mental disorders and mental
disability in the general population. Most population
studies conducted thus far have mainly confined them-
selves to assessing the prevalence rate of BPD diagnosis
and its associated correlates and consequences. Huang
et al. (2009), for example, show that the prevalence rates
of personality disorders (PD) differ between countries,
although the sociodemographic correlates of PD and co-
morbidity with PD of different countries show great
similarity [18]. This implies that our findings on the
prevalence rates of BPD symptoms can perhaps not be
generalized to other countries. The associations between
the number of BPD symptoms and sociodemographic
characteristics, comorbidity of common mental disor-
ders and/or mental disability, on the contrary, could be
generalized to other countries.
Discussion of research findings
In our study, 1.1 % of the population studied reported ≥
5 BPD symptoms. These individuals could be viewed as
having BPD, because they fulfil the required number of
DSM-IV criteria for a BPD diagnosis. This finding concurs
with the assumption made by Lenzenweger et al. [9] that
the average population prevalence of BPD is circa 1 %.
The finding that a greater number of BPD symptoms
is associated with less stable social situations (i.e. not
living with a partner, or having no paid job) confirms
earlier research (e.g. [7, 10, 28]) and is partly inherent
in the definition of BPD; after all, the main character-
istic of BPD is that someone shows a pervasive pattern
of instability in interpersonal relationships, self-image,
and emotions.
One of the findings of our study was that the category
of people with ≥ 5 symptoms consisted of a significantly
higher proportion of females as compared to the cat-
egories of people with 0 or 1–2 symptoms. This con-
trasts with previous population studies, which have
shown no gender differences in the prevalence rate of
BPD (e.g. [4, 5, 10]); yet it confirms the suggestion made
in the DSM-5 that BPD is more common among women
[30] and also substantiates the findings of clinical stud-
ies, which have demonstrated that more women than
men suffer from BPD. However, the gender difference in
clinical studies may result from selection bias (i.e.
women seeking health care more often than men do)
[31]. As a second point, additional analyses based on
data from NEMESIS-2 have revealed that females and
males differ significantly in terms of the type of BPD
symptoms from which they suffer. Females more often
report so-called ‘disturbed relatedness’ symptoms, in
particular: ‘I often feel “empty” inside’ (7.9 % versus
3.6 %), and: ‘When I’m under stress, things around me
don’t seem real’ (8.4 % versus 3.7 %); males, on the other
hand, more often report: ‘I go to extremes to try to keep
people from leaving me’ (10.4 % versus 7.0 %), which is a
symptom of the affective dysregulation dimension [32].
It is unclear whether the gender differences in the num-
ber of BPD symptoms found in the present study reflect
any real differences, or whether women are more likely
to report certain BPD symptoms.
Similar to previous findings (e.g. [7, 8, 10, 18]), in our
study the number of BPD symptoms turned out to be
negatively related to age and education level. As regards
age, this could result from the phenomenon of particular
(i.e. impulsive) symptoms declining as people grow older
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[2, 9]; the education effect could be a consequence of the
disorder itself. After all, BPD is characterized by impulsive
behaviour and an unstable pattern of interacting with
others, which could impede educational achievements.
After adjustment for gender and age, respondents with
a higher number of BPD symptoms were found to be
significantly more likely to suffer from various mental
disorders, including mood, anxiety and substance use
disorders. This is consistent with previous research,
which has shown that BPD is strongly comorbid with a
variety of mental disorders (e.g. [3, 5, 7, 8]) and is closely
associated with both the distress sub-factor of the latent
internalizing dimension and the latent externalizing di-
mension of common mental disorders [33]. These find-
ings lead us to question the extent to which common
mental disorders and personality disorders should be
viewed as distinct, and also the extent to which BPD can
be distinguished clearly from normal variation [12].
Future research might shed more light on these topics,
which could have useful implications for both clinical prac-
tice and the mental health care structure as a whole. With
the elimination of the multi-axial system in the DSM-5,
some artificial distinctions between personality disorders
and other common mental disorders (e.g. mood, anxiety
and substance use disorders) have already disappeared.
The finding that, after adjustment for sociodemo-
graphic characteristics and comorbid mental disorders,
higher numbers of BPD symptoms are uniquely related
to higher mental disability scores is in line with previous
research, which has found an independent contribution
of BPD to mental disability [7, 8] and an independent
contribution of cluster B personality disorders to the
impairment of role functioning and social interaction
[18]. However, our findings contradict another study,
which has found largely reduced effects of BPD on im-
paired functioning after adjustment for comorbid men-
tal disorders [5].
As our study shows, people with a higher number of
BPD symptoms are significantly more likely to use cer-
tain services to deal with their mental health problems;
after adjustment for comorbid mental disorders, how-
ever, these differences largely disappear. This corrobo-
rates previous research, in which higher rates of use of
mental health services were found for people with BPD
as compared to people with any mental disorder [11],
and that people with any personality disorder often seek
treatment for comorbid common mental disorders [18].
However, it contradicts other research which shows that,
after adjustment for demography and comorbid com-
mon mental and personality disorders, people with BPD
are not more likely to seek help from mental health pro-
fessionals [5, 10].
All in all, our findings suggest that people with BPD
seek help mainly for common mental disorders, even
though most of their impairments do not result directly
from these comorbid mental disorders. Thus, it seems
that help-seeking as well as referral to specialized mental
health care by general practitioners is often based on
symptoms rather than traits, probably due to the percep-
tion, among both patients and professionals, of there
being more effective treatment options available for
common mental disorders than for BPD.
Conclusions
Following Tyrer et al. [12], we recommend that not just
full-blown BPD but also subthreshold levels of BPD
symptoms be identified more frequently in clinical prac-
tice and research than is presently the case, as even low
numbers of BPD symptoms were associated with psychi-
atric comorbidity and functional disability.
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